BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 34625078)

  • 1. Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma.
    Zhu C; Li J; Yao M; Fang C
    BMC Oral Health; 2021 Oct; 21(1):506. PubMed ID: 34625078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-Induced Remodeling of the Tumor Microenvironment Through Tumor Cell-Intrinsic Expression of cGAS-STING in Esophageal Squamous Cell Carcinoma.
    Nakajima S; Mimura K; Kaneta A; Saito K; Katagata M; Okayama H; Saito M; Saze Z; Watanabe Y; Hanayama H; Tada T; Sakamoto W; Momma T; Ohira H; Kono K
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):957-971. PubMed ID: 36368436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application.
    Pu F; Chen F; Liu J; Zhang Z; Shao Z
    Onco Targets Ther; 2021; 14():1501-1516. PubMed ID: 33688199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cells.
    Shaikh MH; Bortnik V; McMillan NA; Idris A
    Microb Pathog; 2019 Jul; 132():162-165. PubMed ID: 31054871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer.
    Kabashima A; Matsuo Y; Ito S; Akiyama Y; Ishii T; Shimada S; Masamune A; Tanabe M; Tanaka S
    Sci Rep; 2022 Jun; 12(1):10466. PubMed ID: 35773436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting STING for cancer immunotherapy: From mechanisms to translation.
    Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109304. PubMed ID: 36252492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor cell-intrinsic cGAS-STING pathway is associated with the high density of CD8
    Matsuishi A; Nakajima S; Kaneta A; Saito K; Fukai S; Sakuma M; Tsumuraya H; Okayama H; Saito M; Mimura K; Nirei A; Kikuchi T; Hanayama H; Saze Z; Sakamoto W; Momma T; Kono K
    Esophagus; 2024 Apr; 21(2):165-175. PubMed ID: 38324215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICI-based therapies: A new strategy for oral potentially malignant disorders.
    Wang T; Sun S; Zeng X; Li J
    Oral Oncol; 2023 May; 140():106388. PubMed ID: 37054586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
    Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
    J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
    Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS-STING pathway.
    Guo Y; Shen R; Wang F; Wang Y; Xia P; Wu R; Liu X; Ye W; Tian Y; Wang D
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6315-6328. PubMed ID: 36745223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.
    Pépin G; Gantier MP
    Adv Exp Med Biol; 2017; 1024():175-194. PubMed ID: 28921470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade.
    Wang M; Huang Y; Chen M; Wang W; Wu F; Zhong T; Chen X; Wang F; Li Y; Yu J; Wu M; Chen D
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37620043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.
    Zhang J; Yu S; Peng Q; Wang P; Fang L
    Cancer Biol Med; 2024 Jan; 21(1):45-64. PubMed ID: 38172538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cGAS-STING, an important pathway in cancer immunotherapy.
    Jiang M; Chen P; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; Ye L; He Y; Zhou C
    J Hematol Oncol; 2020 Jun; 13(1):81. PubMed ID: 32571374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Tumor Cell-Intrinsic Expression of Cyclic GMP-AMP Synthase (cGAS)-Stimulator of Interferon Genes (STING) on the Infiltration of CD8
    Nakajima S; Kaneta A; Okayama H; Saito K; Kikuchi T; Endo E; Matsumoto T; Fukai S; Sakuma M; Sato T; Mimura K; Saito M; Saze Z; Sakamoto W; Onozawa H; Momma T; Kono K
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.